Jefferies Group LLC Aldeyra Therapeutics, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 807 shares of ALDX stock, worth $4,438. This represents 0.0% of its overall portfolio holdings.

Number of Shares

807

Holding current value

$4,438

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	SELL	$3.8 - $7.74 $224,933 - $458,153	-59,193 Reduced 98.66%	807 $4,000
Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $3,066 - $6,246	807 New	807 $4,000
Q3 2021 Nov 15, 2021	SELL	$7.94 - $11.31 $476,400 - $678,600	-60,000 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$10.44 - $14.85 $617,974 - $879,016	59,193 Added 7334.94%	60,000 $679,000
Q2 2021 Aug 16, 2021	BUY	$10.44 - $14.85 $626,400 - $891,000	60,000 New	60,000 $680,000
Q4 2019 Feb 13, 2020	SELL	$4.73 - $7.98 $68,987 - $116,388	-14,585 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$4.41 - $6.12 $64,319 - $89,260	14,585 New	14,585 $77,000
Q2 2019 Aug 14, 2019	SELL	$6.0 - $9.0 $120,066 - $180,099	-20,011 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$7.14 - $9.85 $142,878 - $197,108	20,011 New	20,011 $181,000
Q2 2018 Aug 14, 2018	SELL	$6.95 - $9.18 $82,705 - $109,242	-11,900 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$6.55 - $8.9 $77,945 - $105,910	11,900 New	11,900 $89,000

Others Institutions Holding ALDX

# of Institutions

106

Shares Held

35.1M

Call Options Held

153K

Put Options Held

83.9K

Perceptive Advisors LLC New York, NY

9.28M
Shares

$51 Million
0.89% of portfolio
Knoll Capital Management, LLC Miami, FL

5.48M
Shares

$30.1 Million
12.24% of portfolio
Vanguard Group Inc Valley Forge, PA

3.74M
Shares

$20.6 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.62M
Shares

$19.9 Million
0.0% of portfolio
Kennedy Capital Management, Inc. St Louis, MO

1.6M
Shares

$8.8 Million
0.12% of portfolio

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $321M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account